Evaluation of the efficacy of mifepristone/misoprostol and methotrexate/misoprostol for medical abortion

Indian Journal of Medical Sciences

Volumn 59, Issue 7, 2005, Pages 301-306

  Dahiya, K ^a,b   Madan, S ^a   Hooda, R ^a   Sangwan, K ^a   Khosla, A H ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b Model Town ^*  (India)

Author keywords

Abortion; Methotrexate; Mifepristone; Misoprostol

Indexed keywords

METHOTREXATE; MIFEPRISTONE; MISOPROSTOL;

ABORTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FETUS WASTAGE; HEADACHE; HEAT; HUMAN; INDUCED ABORTION; INDUCED HYPOTHERMIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MUSCLE CRAMP; MUSCLE WEAKNESS; NAUSEA; SIDE EFFECT; TREATMENT OUTCOME; VOMITING;

EID: 23344442166     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.16505     Document Type: Article

References (14)

1. Henshaw SK. Induced abortion: a world review. Fam Plann Perspect 1990; 22: 76-89. [Erratum Fam Plann Perspect 1990; 22; 114]
2. Silvestre L, Dubois C, Renault M, Rezvani Y, Baulieu EE, Ginase A. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue: a large-scale French experience. N Eng J Med 1990; 645-8.
3. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Eng J Med 1998; 338: 1241-7.
4. World Health Organisation Task Force on Postovulatory methods of fertility regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br J Obstet Gynaecol 2000; 107: 524-30.
5. el-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone and oral or vaginal misoprostol. N Eng J Med 1995; 3
6. el-Refaey H, Templeton A. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by vaginal route. Contraception Feb 1994; 49(2): 111-4.
7. Creinin MD, Potter C, Holovanigen M. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion. Am J Obstet Gynecol 2003; 188; 664-9.
8. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. A randomized controlled trial comparing misoprostol three and seven days following methotrexate for early abortion. Am J Obstet Gynecol 1995; 173: 1578-81.
9. Creinin MD, Vittinghoff E, Keder L,Darney PD, Tiller G. Methotrexate and misoprostol for early abortion: a multicenter trial.1. Safety and efficacy. Contraception 1996;
10. Wiebe E, Dunn S, Guilbert E, Jacot F, Lugting L. Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol. Obstet Gynecol 2002; 99; 813-9.
11. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 2001; 64: 81-5.
12. Pons JC, Imbert MC, Elefant E, Roux C, Herschkorn P, Papiernik E. Development after exposure to Mifepristone in early pregnancy. Lancet 1991; 338:763.
13. Bawle EV, Conard JV, Weiss L. Adult and two children with fetal methotrexate syndrome. Teratology 1998; 57:51-5.
14. Pastuszak AL, Schuler L, Speck-Martins CE. Use of misoprostol during pregnancy and mobius syndrome in infants. N Eng J Med 1998; 338: 1881-5.